Search results for "molecular microbiology"
Selected Filters:
COVID-19 Spike-ACE2 Binding Assay Kit
RayBiotech Inc.The RayBio® COVID-19 Spike-ACE2 binding assay kit is a rapid, simple, and sensitive method to characterize the binding affinity of the SARS-CoV-2 Spike (S) protein and the Angiotensin I Converting Enzyme 2 (ACE2) receptor complex in the presence of potential inhibitors.
KRIBIOLISA™ Panitumumab (VECTIBIX) ELISA
KRISHGEN BioSystemsThe Palivizumab ELISA kit is intended for the quantitative determination of Palivizumab in serum, plasma and cell culture samples.
Scientists Rate the Synergy Neo2 Multi-Mode Reader from BioTek Instruments Inc.
Find out what the experts really think
InterPlay TAP Purification Buffer Kit
Agilent TechnologiesThe InterPlay TAP Purification Buffer Kit is designed to work with the InterPlay Mammalian TAP System and InterPlay Adenoviral TAP System to recover interacting proteins from mammalian cells. The InterPlay TAP Purification Buffer Kit includes the buffers required to perform tandem affinity purification.
AG-490
STEMCELL Technologies Inc.Tyrosine kinase inhibitor; Inhibits EGFR, HER2, JAK2, JAK3 and STAT5a/b
Metformin
STEMCELL Technologies Inc.AMPK activator; Mitochondrial respiratory chain complex 1 inhibitor
Biomarker Discovery Services
Svar Life Science ABExpert Biomarker Discovery Services using cutting-edge technologies such as high-quality proteomics with Proximity Extension Assay (PEA) technology from Olink, and ultra-sensitive detection with proven Simoa technology. We offer ideal broad screening-to-targeted biomarker discovery solutions in different therapeutic areas.
Hallmark cancer gene regulates RNA ‘dark matter’
Novel findings are a promising step in the development of new tests for cancer diagnostics
RACE act increased the number of cancer drugs with required studies for use in pediatric patients
The RACE act has led to increased requirements for approval of recent pediatric cancer drugs
Early cancer diagnosis: A game-changing blood test for the rapid detection of brain tumors
Mark Hegarty, CEO of Dxcover, reveals how infrared spectroscopy coupled with machine learning could transform the future of cancer diagnosis
New biomarker test accurately predicts progression to Alzheimer’s disease six years before diagnosis
Diadem announces publication of clinical data showing its AlzoSure biomarker test is able to predict progression to Alzheimer’s disease years before symptoms are displayed.
Abbot receives CE mark for its Panbio rapid Antigen Self-Test, opening access throughout Europe to fast, reliable COVID-19 testing
Panbio COVID-19 Antigen Self-Test is approved for sale directly to consumers, enabling fast, convenient coronavirus testing
Solid form screening and selection: Why chemistry-led design brings the greatest value to pharmaceutical development
Guest editorial by Kim James, Solid Form Expert, LGC Drug Development Solutions
6 expert webinars you won't want to miss
Explore topics including multiplexed assays, high-sensitivity troponin, 3D high-resolution X-ray microscopy, CRISPR, and Optimer reagents
The quest for precision medicine: Decoding cancer pathogenesis and overcoming drug resistance
Dr. Komal Kumar Javarappa shares insights from the multidisciplinary forefront of immuno-oncology, where translational biologists race against time to optimize new cancer therapies